Intragastric Pharmacotherapy
An endoscopic treatment combining a gastric balloon with local medication delivery to support medically supervised weight loss.
Patient-Friendly Explanation
Intragastric pharmacotherapy is a treatment approach that combines a gastric balloon with medication delivery directly into the stomach. The balloon helps you feel full sooner while the medicine works locally to support weight loss, offering a non-surgical option that can be placed and removed endoscopically.
Clinical Definition
Intragastric pharmacotherapy refers to an endoscopic intervention where a drug-eluting intragastric balloon is placed in the stomach for 6-12 months. The device combines mechanical gastric distension (volume restriction) with sustained local release of pharmacological agents — typically appetite modulators or metabolic enhancers — directly to the gastric mucosa, bypassing systemic absorption for targeted therapy.
Why It Matters
This emerging hybrid approach offers a bridge between medication-only treatment and invasive bariatric surgery. For patients who need more than oral medication but are not candidates for surgery, it provides a meaningful intermediate option with a favourable safety profile.
This library is for general education and does not replace individual assessment by a qualified healthcare professional. Always consult a doctor for medical advice, diagnosis, or treatment.
Ready to Start Your Journey?
Book a Free Weight Management Consultation with our doctor today.
Book Free Consultation →